期刊文献+

彩色多普勒超声诊断肾癌及术前分期评价

The diagnosis and preoperative staging evaluation value of color doppler ultrasound in renal cancer
原文传递
导出
摘要 目的探讨彩色多普勒超声对肾癌诊断和分期的应用价值。方法选取2008年12月至2013年12月间收治的120例经术后病理证实为肾癌的患者,所有患者术前均进行了彩色多普勒超声检查和CT检查,分析患者超声和CT图像特征,比较二者的诊断准确率和分期符合率。结果超声和CT诊断肾癌的准确率分别为87.5%和91.7%,差异无统计学意义(P>0.05);超声和CT分期符合率分别为82.5%和79.2%,差异无统计学意义(P>0.05)。结论与后病理比较,彩色多普勒超声检查对肾癌的分期具有较高的符合率。超声检查有望成为肾癌检查手段,并能为肾癌患者的临床治疗和预后提供参考依据。 Objective To explore the clinical value of color Doppler ultrasound in the diagnosis and preoperative staging evaluation of renal cell carcinoma (RCC). Methods From December 2008 to December 2013 ,a total of 120 suspected RCCs were enrolled into this study, all patients were examined with color Doppler ultrasonography and CT examination, the pictures of ultrasonography and CT were analyzed, diagnostic accuracy and staging compliance rate were compared. Results Compared with pathological results, the diagnostic accuracy of Color Doppler Ultrasound (87.5%) was lower than that of CT examination ( 91.7% ), but the difference was not significant ( P 〉 0.05 ) ; The staging compliance rate of Color Doppler Ultrasound (82. 5% ) was slightly higher than that of CT examination (79. 2% ), but the difference was not significant (P 〉 0. 05 ). Conclusion Compared with pathological results, the staging evaluation of renal cell carcinoma with Color Doppler ultrasound has a higher compliance rate. Ultrasound is expected to be widely used in the RCC inspection, and can provide reference for clinical treatment and prognosis of kidney cancer patients.
作者 王彤
出处 《中国肿瘤临床与康复》 2014年第8期928-930,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肾肿瘤 彩色多普勒超声 术前分期 Kidney neoplasms Color Doppler Ultrasound Preoperative staging evaluation
  • 相关文献

参考文献7

二级参考文献33

  • 1阎红焱.超声诊断肾血管平滑肌脂肪瘤[J].中国医学影像技术,2004,20(z1):80-81. 被引量:5
  • 2Moch H, Artibani W, Delahunt B, et al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol, 2009, 56: 636-643.
  • 3Klatte T, Patard J J, Goel RH, et al. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international muhicenter ex- perience. J Urol, 2007, 178: 35-40: 40.
  • 4Thompson RH, Cheville JC, Lohsc CM, et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer, 2005, 104: 53-60.
  • 5Frank I, Blute ML, Leibovich BC, et al. pT2 classification for re- nal cell carcinoma. Can its accuracy be improved?. J Urol, 2005, 173, 380-384.
  • 6Han KR, Bui MH, Pantuck AJ, et al. TNM T3a renal cell carci- noma: adrenal gland involvement is not the same as renal fat inva- sion. J Urol, 2003, 169: 899-904.
  • 7Thompson RH, Leibovieh BC, Chevine JC, et al. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?. J Urol, 2005, 173 : 918-921.
  • 8Lam JS, Klatte T, Patard JJ, et al. Prognostic relevance of tumour size in T3a renal cell carcinoma: a muhicentre experience. Eur Urol, 2007, 52: 155-162.
  • 9Novara G, Ficarra V, Antonelli A, et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?. Eur Urol, 2010, 58: 588-595.
  • 10Eggener S. TNM staging for renal cell carcinoma: time for a new method. EurUrol, 2010, 58: 517-519, 519-521.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部